The vitamin K can be consumed orally, as a dietary supplement. It is found in the form of capsules, drinkable solutions, or tablets. The dosages available on the market are approximately 25 to 100 µg per day.
It is important to note that dietary supplements containing vitamin K are currently used exclusively for medical purposes to address a deficiency in vitamin K or a blood coagulation issue.
Nevertheless, studies reveal a potential effect of vitamin Kp on the skin, particularly in the context of skin conditions such as the psoriasis. A defined mechanism has recently been proposed through Toll-like receptors (TLR), pro-inflammatory receptors involved in atherosclerosis, which is a fatty deposit in the arteries.
The study, conducted by Jinchuan YAN and his team, utilised vitamin K supplementation in mice to detect its effect on arterial calcification and associated inflammation. After 12 weeks of oral administration of 40mg/kg/day of vitamin K, a significant decrease in the expression of TLR2 and TLR4 was observed in aortic tissues.
This study is a significant discovery, as psoriasis exhibits an aberrant expression of these receptors in the epidermis. This could therefore suggest a role for Vitamin K in the management of psoriasis.
Further research is required to determine the role of Vitamin K in the expression of TLR in the epidermis, and clinical trials on patients with psoriasis may be of interest.